Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2003-5-27
pubmed:abstractText
Malignant mesothelioma (MM) is a lethal tumor linked with a prior exposure to asbestos in which limited progress has been made so far using conventional therapies. MM is an example of a "nonimmunogenic" tumor characterized by a fibrous stroma and an absence of infiltrating T lymphocytes. High levels of transforming growth factor-beta (TGF-beta) produced by mesothelioma cells have been related to the immune tolerance towards the tumor. In order to evaluate the effect of local delivery of cytokines such as interferon gamma (IFN-gamma) by gene transfer, we characterized and used a murine model, AK7, which appeared very similar to human mesothelioma. AK7 cells expressed low levels of major histocompatibility class I and class II antigens and secreted high levels of latent TGF-beta. The TGF-beta pathway in AK7 cells is operative but inefficient because endogenous TGF-beta is predominantly inactive. Treatment of pre-established AK7 tumors by direct intratumoral injection of an adenovirus vector expressing murine IFN-gamma, Ad.mIFN-gamma, led to significant tumor regression. Peripheral tumor infiltration by CD4+ and CD8+ T lymphocytes in the treated tumors appeared to be because of the induction of an immune response. Tumor relapse was observed, which could be due to local TGF-beta secretion by remaining tumor cells.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0929-1903
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
481-90
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:12768194-Adenoviridae, pubmed-meshheading:12768194-Animals, pubmed-meshheading:12768194-Apoptosis, pubmed-meshheading:12768194-Blotting, Western, pubmed-meshheading:12768194-Caspase 3, pubmed-meshheading:12768194-Caspases, pubmed-meshheading:12768194-Cell Line, Tumor, pubmed-meshheading:12768194-Cell Separation, pubmed-meshheading:12768194-Cytokines, pubmed-meshheading:12768194-DNA, Complementary, pubmed-meshheading:12768194-Down-Regulation, pubmed-meshheading:12768194-Female, pubmed-meshheading:12768194-Flow Cytometry, pubmed-meshheading:12768194-Gene Therapy, pubmed-meshheading:12768194-Gene Transfer Techniques, pubmed-meshheading:12768194-Immunohistochemistry, pubmed-meshheading:12768194-Interferon-gamma, pubmed-meshheading:12768194-Mesothelioma, pubmed-meshheading:12768194-Mice, pubmed-meshheading:12768194-Mice, Inbred C57BL, pubmed-meshheading:12768194-Neoplasm Transplantation, pubmed-meshheading:12768194-Phosphorylation, pubmed-meshheading:12768194-Polymerase Chain Reaction, pubmed-meshheading:12768194-RNA, pubmed-meshheading:12768194-T-Lymphocytes, pubmed-meshheading:12768194-Time Factors, pubmed-meshheading:12768194-Transforming Growth Factor beta, pubmed-meshheading:12768194-Up-Regulation
pubmed:year
2003
pubmed:articleTitle
Regression of AK7 malignant mesothelioma established in immunocompetent mice following intratumoral gene transfer of interferon gamma.
pubmed:affiliation
Institut Gustave Roussy, 94805 Villejuif Cedex, France.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't